Suppr超能文献

肥胖诱导的肠道和脂肪组织生态失调在2型糖尿病中的最新见解。

Recent insights of obesity-induced gut and adipose tissue dysbiosis in type 2 diabetes.

作者信息

Patra Debarun, Banerjee Dipanjan, Ramprasad Palla, Roy Soumyajit, Pal Durba, Dasgupta Suman

机构信息

Department of Biomedical Engineering, Indian Institute of Technology Ropar, Punjab, Punjab, India.

Department of Molecular Biology and Biotechnology, Tezpur University, Napaam, Assam, India.

出版信息

Front Mol Biosci. 2023 Sep 28;10:1224982. doi: 10.3389/fmolb.2023.1224982. eCollection 2023.

Abstract

An imbalance in microbial homeostasis, referred to as dysbiosis, is critically associated with the progression of obesity-induced metabolic disorders including type 2 diabetes (T2D). Alteration in gut microbial diversity and the abundance of pathogenic bacteria disrupt metabolic homeostasis and potentiate chronic inflammation, due to intestinal leakage or release of a diverse range of microbial metabolites. The obesity-associated shifts in gut microbial diversity worsen the triglyceride and cholesterol level that regulates adipogenesis, lipolysis, and fatty acid oxidation. Moreover, an intricate interaction of the gut-brain axis coupled with the altered microbiome profile and microbiome-derived metabolites disrupt bidirectional communication for instigating insulin resistance. Furthermore, a distinct microbial community within visceral adipose tissue is associated with its dysfunction in obese T2D individuals. The specific bacterial signature was found in the mesenteric adipose tissue of T2D patients. Recently, it has been shown that in Crohn's disease, the gut-derived bacterium translocated to the mesenteric adipose tissue and modulates its function by inducing M2 macrophage polarization, increasing adipogenesis, and promoting microbial surveillance. Considering these facts, modulation of microbiota in the gut and adipose tissue could serve as one of the contemporary approaches to manage T2D by using prebiotics, probiotics, or faecal microbial transplantation. Altogether, this review consolidates the current knowledge on gut and adipose tissue dysbiosis and its role in the development and progression of obesity-induced T2D. It emphasizes the significance of the gut microbiota and its metabolites as well as the alteration of adipose tissue microbiome profile for promoting adipose tissue dysfunction, and identifying novel therapeutic strategies, providing valuable insights and directions for future research and potential clinical interventions.

摘要

微生物稳态失衡,即生态失调,与肥胖诱导的代谢紊乱(包括2型糖尿病(T2D))的进展密切相关。肠道微生物多样性的改变和病原菌数量的增加会破坏代谢稳态,并因肠道渗漏或多种微生物代谢产物的释放而加剧慢性炎症。与肥胖相关的肠道微生物多样性变化会使调节脂肪生成、脂肪分解和脂肪酸氧化的甘油三酯和胆固醇水平恶化。此外,肠道-脑轴的复杂相互作用,加上微生物群谱和微生物衍生代谢产物的改变,会破坏双向通讯,从而引发胰岛素抵抗。此外,内脏脂肪组织内独特的微生物群落与其在肥胖T2D个体中的功能障碍有关。在T2D患者的肠系膜脂肪组织中发现了特定的细菌特征。最近的研究表明,在克罗恩病中,源自肠道的细菌转移至肠系膜脂肪组织,并通过诱导M2巨噬细胞极化、增加脂肪生成和促进微生物监测来调节其功能。考虑到这些事实,通过使用益生元、益生菌或粪便微生物移植来调节肠道和脂肪组织中的微生物群,可能是管理T2D的当代方法之一。总之,本综述整合了关于肠道和脂肪组织生态失调及其在肥胖诱导的T2D发生和发展中作用的现有知识。它强调了肠道微生物群及其代谢产物的重要性,以及脂肪组织微生物群谱的改变对促进脂肪组织功能障碍的影响,并确定了新的治疗策略,为未来的研究和潜在的临床干预提供了有价值的见解和方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0954/10575740/252dd02c8864/fmolb-10-1224982-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验